Home › Companies › Niagen Bioscience, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Niagen Bioscience, Inc.’s Form 8-K, filed 2026-06-29 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore Niagen Bioscience, Inc. in the interactive database Compare manager voting policies
These tallies are Niagen Bioscience, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-29 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Frank L. Jaksch, Jr. | 44,531,507 | -- | -- | 759,870 | 13,274,979 | Majority: yes |
| Elect Director: Robert Fried | 44,822,825 | -- | -- | 468,552 | 13,274,979 | Majority: yes |
| Elect Director: Steven Rubin | 28,495,147 | -- | -- | 16,796,230 | 13,274,979 | Majority: yes |
| Elect Director: Wendy Yu | 44,520,972 | -- | -- | 770,405 | 13,274,979 | Majority: yes |
| Elect Director: Gary Ng | 44,446,052 | -- | -- | 845,325 | 13,274,979 | Majority: yes |
| Elect Director: Kristin Patrick | 43,608,014 | -- | -- | 1,683,363 | 13,274,979 | Majority: yes |
| Elect Director: Ann Cohen | 44,360,218 | -- | -- | 931,159 | 13,274,979 | Majority: yes |
| Elect Director: Hamed Shahbazi | 30,544,086 | -- | -- | 14,747,291 | 13,274,979 | Majority: yes |
| Proposal 2: Ratification of the appointment of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | 56,152,066 | 2,256,090 | 158,200 | -- | -- | Majority: yes |
| Proposal 3: Approval, on an advisory basis, of the compensation paid to the Company's named executive officers. | 43,188,958 | 1,930,441 | 171,978 | -- | 13,274,979 | Majority: yes |
Source: Niagen Bioscience, Inc., Form 8-K, filed with the SEC on 2026-06-29 — read the filing on EDGAR.
Each item below shows how the 153 asset managers that disclosed a Niagen Bioscience, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Proposal 3: Approval, on an advisory basis, of the compensation paid to the Company's named executive officers.”): 43,188,958 for, 1,930,441 against, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 54.2% for, 2% against (57% of the company cast a for/against vote).
The 153 asset managers below cast 97% of the shares they voted on this item FOR (19,232,490 for, 619,746 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,792,291 | 16 | 2 | 0 | For |
| BlackRock | 2,274,919 | 22,889 | 0 | 0 | For |
| Tieton Capital Management, LLC | 1,456,000 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,260,192 | 0 | 0 | 0 | For |
| Fidelity | 1,106,210 | 0 | 0 | 0 | For |
| Charles Schwab | 893,874 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 863,155 | 9,413 | 0 | 0 | For |
| State Street | 800,950 | 1,946 | 0 | 0 | For |
| Victory Capital | 752,103 | 0 | 0 | 0 | For |
| AQR | 481,249 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 434,039 | 0 | 0 | 0 | For |
| SEI | 407,794 | 0 | 0 | 0 | For |
| Maryland State Retirement & Pension System | 394,990 | 0 | 0 | 0 | For |
| Goldman Sachs | 382,568 | 0 | 0 | 0 | For |
| AllianceBernstein | 374,474 | 0 | 0 | 0 | For |
| Dimensional | 0 | 324,573 | 0 | 0 | Against |
| Gabelli | 295,435 | 0 | 0 | 0 | For |
| Northern Trust | 211,930 | 0 | 0 | 0 | For |
| T. Rowe Price | 195,553 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 179,771 | 0 | 0 | 0 | For |
| DE Shaw | 158,816 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 148,167 | 0 | 0 | 0 | For |
| RBC Dominion Securities Inc. | 124,890 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Nuveen | 123,270 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. See all 153 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Ann Cohen”): 44,360,218 for, 931,159 withheld, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 56% for, 1% withheld (57% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (8,306,044 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,390,783 | 0 | 3,880 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Frank L. Jaksch, Jr.”): 44,531,507 for, 759,870 withheld, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 56% for, 1.0% withheld (57% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (8,172,753 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,382,964 | 0 | 11,699 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 0 | 120,409 | 0 | Abstain |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Gary Ng”): 44,446,052 for, 845,325 withheld, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 56% for, 1% withheld (57% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (8,309,916 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,655 | 0 | 8 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
67% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Hamed Shahbazi”): 30,544,086 for, 14,747,291 withheld, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 38% for, 19% withheld (57% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (1,979,286 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,232,352 | 0 | 2,162,312 | 0 | Abstain |
| Fidelity | 342 | 0 | 1,086,152 | 0 | Abstain |
| BlackRock | 0 | 0 | 927,565 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 446,466 | 0 | Abstain |
| Victory Capital | 0 | 0 | 324,790 | 0 | Abstain |
| Dimensional | 0 | 0 | 273,512 | 0 | Abstain |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 203,824 | 0 | Abstain |
| AllianceBernstein | 0 | 0 | 170,962 | 0 | Abstain |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 123,405 | 0 | Abstain |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 111,122 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 88,560 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 73,746 | 0 | Abstain |
| Nationwide | 5,628 | 0 | 38,390 | 0 | Abstain |
| Lincoln Financial | 37,200 | 0 | 5,572 | 0 | For |
| WisdomTree | 0 | 0 | 35,746 | 0 | Abstain |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 35,044 | 0 | Abstain |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 28,345 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 26,659 | 0 | Abstain |
| Global X | 0 | 0 | 23,310 | 0 | Abstain |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Kristin Patrick”): 43,608,014 for, 1,683,363 withheld, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 54.8% for, 2% withheld (57% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (8,262,874 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,645 | 0 | 18 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,572 | 0 | 37,200 | 0 | Abstain |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Robert Fried”): 44,822,825 for, 468,552 withheld, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 56% for, 0.6% withheld (57% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (8,309,919 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,658 | 0 | 5 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 3 wordings of this item as funds reported it.
63% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Steven Rubin”): 28,495,147 for, 16,796,230 withheld, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 36% for, 21% withheld (57% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (734,455 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,594 | 0 | 3,378,069 | 0 | Abstain |
| Fidelity | 0 | 0 | 1,086,494 | 0 | Abstain |
| BlackRock | 0 | 0 | 927,565 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 446,466 | 0 | Abstain |
| Victory Capital | 0 | 0 | 324,790 | 0 | Abstain |
| Dimensional | 0 | 0 | 273,512 | 0 | Abstain |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 203,824 | 0 | Abstain |
| AllianceBernstein | 0 | 0 | 170,962 | 0 | Abstain |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 123,405 | 0 | Abstain |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 111,122 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 88,560 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 73,746 | 0 | Abstain |
| Nationwide | 5,628 | 0 | 38,390 | 0 | Abstain |
| Lincoln Financial | 37,200 | 0 | 5,572 | 0 | For |
| WisdomTree | 0 | 0 | 35,746 | 0 | Abstain |
| JPMorgan | 0 | 0 | 35,420 | 0 | Abstain |
| American Century | 0 | 0 | 35,044 | 0 | Abstain |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 28,345 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 26,659 | 0 | Abstain |
| Global X | 0 | 0 | 23,310 | 0 | Abstain |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Elect Director: Wendy Yu”): 44,520,972 for, 770,405 withheld, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 56% for, 1.0% withheld (57% of the company cast a for/withheld vote).
The 51 asset managers below cast 100% of the shares they voted on this item FOR (8,305,119 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,655 | 0 | 8 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 117,553 | 0 | 0 | 0 | For |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Niagen Bioscience, Inc.’s own tally for this item (“Proposal 2: Ratification of the appointment of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 56,152,066 for, 2,256,090 against, per its Form 8-K filed 2026-06-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 79,644,327 outstanding shares: 71% for, 3% against (73% of the company cast a for/against vote).
The 51 asset managers below cast 99% of the shares they voted on this item FOR (8,209,139 for, 100,783 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,394,643 | 18 | 2 | 0 | For |
| Fidelity | 1,086,494 | 0 | 0 | 0 | For |
| BlackRock | 927,565 | 0 | 0 | 0 | For |
| Charles Schwab | 446,466 | 0 | 0 | 0 | For |
| Victory Capital | 324,790 | 0 | 0 | 0 | For |
| Dimensional | 273,512 | 0 | 0 | 0 | For |
| Gabelli | 223,685 | 0 | 0 | 0 | For |
| SEI | 203,824 | 0 | 0 | 0 | For |
| AllianceBernstein | 170,962 | 0 | 0 | 0 | For |
| Goldman Sachs | 144,310 | 0 | 0 | 0 | For |
| Equitable | 123,405 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 120,409 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 16,788 | 100,765 | 0 | 0 | Against |
| TIAA | 111,122 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 88,560 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,746 | 0 | 0 | 0 | For |
| Nationwide | 44,018 | 0 | 0 | 0 | For |
| Lincoln Financial | 42,772 | 0 | 0 | 0 | For |
| WisdomTree | 35,746 | 0 | 0 | 0 | For |
| JPMorgan | 35,420 | 0 | 0 | 0 | For |
| American Century | 35,044 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 30,000 | 0 | 0 | 0 | For |
| AQR | 28,345 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 26,659 | 0 | 0 | 0 | For |
| Global X | 23,310 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Ranked by the number of Niagen Bioscience, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 79,644,327 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.76% |
| 2 | BlackRock | 2.89% |
| 3 | Tieton Capital Management, LLC | 1.83% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.58% |
| 5 | Fidelity | 1.39% |
| 6 | Charles Schwab | 1.12% |
| 7 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.10% |
| 8 | State Street | 1.01% |
| 9 | Victory Capital | 0.94% |
| 10 | AQR | 0.60% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Chau Hoi Shuen Solina Holly | 24.23% | DEF14A |
| Robert Fried | 5.86% | DEF14A |
| BlackRock | 4.86% | 13F |
| Vanguard Group | 4.13% | 13F |
| Frank L. Jaksch, Jr. | 3.49% | DEF14A |
| Geode Capital | 1.69% | 13F |
| Renaissance Technologies | 1.67% | 13F |
| Goldman Sachs | 1.57% | 13F |
| State Street | 1.36% | 13F |
| Dimensional Fund Advisors | 1.34% | 13F |
Percentages above are of 79,644,327 shares outstanding, as reported by Niagen Bioscience, Inc. on its Form 10-Q dated 2026-05-04 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Niagen Bioscience, Inc.’s 10-Q dated 2026-05-04. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Niagen Bioscience, Inc.'s shareholder meeting held 2026-06-24, in the 2025-2026 proxy season, 153 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 1,625 separate fund positions. On the most widely held item on that ballot — A nonbinding advisory vote of the Company's stockholders, as recommended by the Compensation… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Niagen Bioscience, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-29.
Niagen Bioscience, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).